| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002361932 |
| P356 | DOI | 10.1038/338762A0 |
| P698 | PubMed publication ID | 2524005 |
| P2093 | author name string | R J Naylor | |
| N M Barnes | |||
| J M Barnes | |||
| B Costall | |||
| M B Tyers | |||
| P2860 | cites work | Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain | Q28305760 |
| Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain | Q28360220 | ||
| Zacopride, a potent 5-HT3 antagonist | Q34560485 | ||
| Zacopride: anxiolytic profile in rodent and primate models of anxiety | Q34560492 | ||
| The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist | Q35755424 | ||
| Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones | Q39803397 | ||
| Inhibition of striatal acetylcholine release by endogenous serotonin | Q41412232 | ||
| Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors | Q41840952 | ||
| Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve | Q42565964 | ||
| [3H]zacopride: ligand for the identification of 5-HT3 recognition sites | Q46157404 | ||
| Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding | Q48170120 | ||
| Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect | Q48431224 | ||
| Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs | Q48470318 | ||
| Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells. | Q53856611 | ||
| Blockade of neuronal tryptamine receptors by metoclopramide | Q67340854 | ||
| Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons | Q70755506 | ||
| Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum | Q71670329 | ||
| P433 | issue | 6218 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 762-763 | |
| P577 | publication date | 1989-04-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue | |
| P478 | volume | 338 |
| Q37295090 | 5-HT receptors: subtypes and second messengers |
| Q35888271 | 5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs |
| Q70674112 | 5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex |
| Q43576861 | 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study |
| Q48474428 | 5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release |
| Q43632183 | A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia |
| Q28142963 | A review of central 5-HT receptors and their function |
| Q41454730 | Acetylcholine, aging, and Alzheimer's disease |
| Q55484075 | Activation and desensitization of the 5-HT3 receptor in a rat glioma x mouse neuroblastoma hybrid cell |
| Q28277447 | Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results |
| Q60644608 | Alcohol-induced reinforcement: Dopamine and 5-HT3 receptor interactions in animals and humans |
| Q51588124 | Attenuating effect of serotonin receptor antagonists on impairment of mealtime-associated activity rhythm in old rats |
| Q42551626 | Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain |
| Q35942094 | Behavioural pharmacology of 5-HT3 receptor ligands |
| Q48606957 | Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation |
| Q34158002 | Central 5-HT(3) receptors and water intake in rats |
| Q41689855 | Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding |
| Q42716106 | Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens |
| Q41376834 | Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease |
| Q44025232 | Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze |
| Q38547971 | Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex |
| Q52048174 | Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. |
| Q42281538 | DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats |
| Q36972797 | Diagnostic and pharmacological approaches in Alzheimer's disease |
| Q48658644 | Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats |
| Q48399495 | Differential interaction between 5-HT3 receptors and GABAergic neurons inhibiting acetylcholine release in rat entorhinal cortex slices |
| Q43904349 | Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system |
| Q34671692 | Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism |
| Q48195888 | Dorsal facial area of cat medulla; 5-HT2 action on glutamate release in regulating common carotid blood flow |
| Q48810166 | Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist |
| Q73250922 | Effect of dotarizine on K(+)-stimulated [3H]-serotonin and [3H]-acetylcholine release from rat hippocampus |
| Q45342938 | Effects of combined serotonin depletion and lesions of the nucleus basalis magnocellularis on acquisition of a complex spatial discrimination task in the rat |
| Q51124081 | Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex |
| Q74014946 | Effects of serotonergic agents on the transport response in rats |
| Q51652337 | Enteric GABA-containing nerves projecting to the guinea-pig inferior mesenteric ganglion modulate acetylcholine release. |
| Q48580740 | Evidence for 5-HT4 receptor involvement in the enhancement of acetylcholine release by p-chloroamphetamine in rat frontal cortex |
| Q48555104 | Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat. |
| Q44502847 | Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats |
| Q48231354 | Forebrain serotonin depletion facilitates the acquisition and performance of a conditional visual discrimination task in rats. |
| Q41834801 | Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain |
| Q36711574 | Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic |
| Q41582787 | How to express an effect mean as percentage of a control mean? |
| Q48581509 | Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: an in vivo microdialysis study |
| Q46092796 | Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat |
| Q35888694 | Influence of acute and chronic chlorimipramine treatment on the 5-HT receptor-mediated modulation of acetylcholine release from the cerebral cortex of freely moving guinea-pigs |
| Q46703632 | Inhibition of [3H] γ‐aminobutyric acid release from guinea‐pig hippocampal synaptosomes by serotonergic agents |
| Q30430384 | Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus. |
| Q46023038 | Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197. |
| Q52095037 | Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance |
| Q41628465 | Modulation of acetylcholine release in human cortical slices: possible implications for Alzheimer's disease |
| Q48875017 | Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons |
| Q37047695 | Molecular modeling of 5-HT3 receptor ligands |
| Q72741950 | Monoamines modulate the electrically-evoked efflux of 3H-choline from slices of guinea pig nucleus basalis magnocellularis |
| Q44330764 | Multiple heteroreceptors on limbic thalamic axons: M2 acetylcholine, serotonn1B, β2‐adrenoceptors, μ‐opioid, and neurotensin |
| Q41629871 | Multiple serotonin receptors: too many, not enough, or just the right number? |
| Q40422758 | Neuropsychiatric manifestations of diffuse Lewy body disease |
| Q57913221 | Nicotine and tetrahydroaminoacradine: Evidence for improved attention in patients with dementia of the Alzheimer type |
| Q43824587 | Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate |
| Q52052069 | Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. |
| Q41910003 | Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo |
| Q48388044 | Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses |
| Q45947297 | Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity. |
| Q43715394 | Potentiation of 5-HT(3) receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments |
| Q51520737 | Presynaptic 5-HT3 receptors evoke an excitatory response in dorsal vagal preganglionic neurones in anaesthetized rats. |
| Q68840289 | Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990 |
| Q33952451 | R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats |
| Q44347231 | Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. |
| Q52508441 | Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. |
| Q36529888 | Serotonergic modulation of Neural activities in the entorhinal cortex |
| Q52052081 | Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans. |
| Q48180682 | Serotonergic modulation of plasticity of the auditory cortex elicited by fear conditioning |
| Q38004413 | Serotonin receptor "families" in the central nervous system: an overview |
| Q40086536 | Sir David Jack: an extraordinary drug discoverer and developer |
| Q52013141 | Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats. |
| Q48445308 | The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats |
| Q46072552 | The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. |
| Q52173814 | The GABA(B) receptor antagonist CGP36742 improves learned helplessness in rats. |
| Q53868007 | The Inhibitory Effect of Trifluoromethylphenylpiperazine on [3H]Acetylcholine Release in Guinea Pig Hippocampal Synaptosomes Is Mediated by a 5-Hydroxytryptamine1Receptor Distinct from 1A, 1B, and 1C Subtypes |
| Q37685759 | The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target? |
| Q52238849 | The effect of ondansetron on cognitive performance in the marmoset |
| Q48774063 | The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys |
| Q51995538 | The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. |
| Q41969040 | The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro |
| Q41331950 | The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications |
| Q54017665 | The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models. |
| Q52210284 | The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. |
| Q48831002 | The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor |
| Q48386995 | Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat. |
| Q52041002 | Twenty years of cholinergic intervention in Alzheimer's disease: A tale of disappointment and ultimate confidence. |
| Q60711583 | [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion |
Search more.